-
EP1311287
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1311287
| EP1311287 - TRANSGLUTAMINASE FOR INHIBITING ANGIOGENESIS [Right-click to bookmark this link] | Status | The application has been refused Status updated on 25.06.2010 Database last updated on 04.11.2024 | Most recent event Tooltip | 25.06.2010 | Refusal of application | published on 28.07.2010 [2010/30] | Applicant(s) | For all designated states Aston University Aston Triangle Birmingham B4 7ET / GB | [2006/50] |
| Former [2006/40] | For all designated states The Nottingham Trent University Burton Street Nottingham NG1 4BU / GB | ||
| Former [2003/21] | For all designated states The Nottingham Trent University Clifton Lane, Faculty of Science and Mathematics Nottingham NG11 8NS / GB | Inventor(s) | 01 /
GRIFFIN, Martin Rivendell, Main Street, Bleasby Nottinghamshire, NG14 7GH / GB | 02 /
JONES, Richard, The Nottingham Trent University Faculty of Science & Mathematics, Clifton Lane Nottingham NG11 8NS / GB | [2009/14] |
| Former [2003/21] | 01 /
GRIFFIN, Martin, The Nottingham Trent University Faculty of Science & Mathematics, Clifton Lane Nottingham NG11 8NS / GB | ||
| 02 /
JONES, Richard, The Nottingham Trent University Faculty of Science & Mathematics, Clifton Lane Nottingham NG11 8NS / GB | Representative(s) | Smith, Stephen Edward, et al Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
| Former [2006/50] | Smith, Stephen Edward, et al Eric Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | ||
| Former [2003/21] | Thomas, Philip John Duval, et al Eric Potter Clarkson, Park View House, 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 01954205.9 | 08.08.2001 | [2003/21] | WO2001GB03574 | Priority number, date | GB20000019302 | 08.08.2000 Original published format: GB 0019302 | [2003/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0211747 | Date: | 14.02.2002 | Language: | EN | [2002/07] | Type: | A2 Application without search report | No.: | EP1311287 | Date: | 21.05.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.02.2002 takes the place of the publication of the European patent application. | [2003/21] | Search report(s) | International search report - published on: | EP | 08.08.2002 | Classification | IPC: | A61K38/45, A61K47/48, A61K48/00, A61P35/00, A61P17/06, A61P19/02, A61P27/02 | [2003/21] | CPC: |
A61K38/45 (EP,US);
A61P17/06 (EP);
A61P19/02 (EP);
A61P27/02 (EP);
A61P35/00 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/21] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | TRANSGLUTAMINASE ZUR HEMMUNG DER ANGIOGENESE | [2003/21] | English: | TRANSGLUTAMINASE FOR INHIBITING ANGIOGENESIS | [2003/21] | French: | TRANSGLUTAMINASE POUR L'INHIBITION DE L'ANGIOGENESE | [2003/21] | Entry into regional phase | 10.02.2003 | National basic fee paid | 10.02.2003 | Designation fee(s) paid | 10.02.2003 | Examination fee paid | Examination procedure | 04.03.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 31.01.2003 | Amendment by applicant (claims and/or description) | 10.02.2003 | Examination requested [2003/21] | 17.06.2005 | Despatch of a communication from the examining division (Time limit: M06) | 15.12.2005 | Reply to a communication from the examining division | 06.12.2006 | Despatch of a communication from the examining division (Time limit: M06) | 08.06.2007 | Reply to a communication from the examining division | 23.02.2010 | Cancellation of oral proceeding that was planned for 02.03.2010 | 02.03.2010 | Date of oral proceedings (cancelled) | 11.03.2010 | Despatch of communication that the application is refused, reason: substantive examination [2010/30] | 21.03.2010 | Application refused, date of legal effect [2010/30] | Fees paid | Renewal fee | 13.08.2003 | Renewal fee patent year 03 | 12.08.2004 | Renewal fee patent year 04 | 27.02.2006 | Renewal fee patent year 05 | 14.08.2006 | Renewal fee patent year 06 | 14.08.2007 | Renewal fee patent year 07 | 31.03.2008 | Renewal fee patent year 08 | 12.08.2009 | Renewal fee patent year 09 | Penalty fee | Additional fee for renewal fee | 31.08.2005 | 05 M06 Fee paid on 27.02.2006 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US5885808 (SPOONER ROBERT ANTHONY [GB], et al) [Y] 9-13,21-25 * column 3, line 45 - column 5, line 16; claim - * * column 7, line 63 - column 9, line 36 *; | [D]WO9410323 (IMP CANCER RES TECH [GB], et al); | [XY] - Z.A. HAROON ET AL., "Recombinant human tissue transglutaminase modifies angiogenesis and delays mammary tumor growth in vivo.", FASEB JOURNAL FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, (19960430), vol. 10, no. 6, page a1416, XP002196009 [X] 1-8,14,18-20,26-31 * abstract 2403 * [Y] 9-13,15-17,21-25 | [DY] - FOLKMAN J, "ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE", NATURE MEDICINE, NATURE PUBLISHING, CO, US, (1995), vol. 1, no. 1, ISSN 1078-8956, pages 27 - 31, XP000605147 [DY] 15-17 * the whole document * DOI: http://dx.doi.org/10.1038/nm0195-27 | [DA] - Z. HAROON ET AL., "Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis.", FASEB JOURNAL FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, (199910), vol. 13, pages 1787 - 1795, XP002196010 [DA] 1-31 * page 1794, column R, paragraph L * | Examination | - HAROON Z.A. ET AL, "Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth", LABORATORY INVESTIGATION, (1999), vol. 79, pages 1679 - 1686, XP008017379 |